News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Allstate beat Q3 and showed Protection Services momentum, prompting a tactical long bet on normalization and multiple expansion.
  • Coeur Mining fell after weather and downtime hit Q3 production but retains strong cash and low leverage for a rebound.
  • WPP's AI initiatives moved beyond pilots, improving technicals and yield and creating a tactical long if billable work materializes.
  • Analysts published specific entry, stop and target levels across these stocks for roughly 45 trading day tactical trades.
  • Collectively, the trade calls signal selective risk-on interest in undervalued insurance, mining and ad services names.

Latest Articles

Riverview Bancorp Declares 47th Consecutive Quarterly Cash Dividend

Riverview Bancorp Declares 47th Consecutive Quarterly Cash Dividend

Riverview Bancorp, Inc. announced that its Board of Directors approved a quarterly cash dividend of $0.02 per share, unchanged from the previous quarter. This marks the company's 47th consecutive quarterly dividend. The dividend will be paid on October 20, 2026, to shareholders of record as of October 9, 2026. Riverview Bancorp operates as a commun…

All In FutureTech Alliance Inc. Launches New Corporate Website, Highlighting Its AI-Driven Business Strategy and Global Platform Vision

All In FutureTech Alliance Inc. Launches New Corporate Website, Highlighting Its AI-Driven Business Strategy and Global Platform Vision

All In FutureTech Alliance Inc. (NASDAQ: AIFA) has launched a new corporate website to better communicate its AI-focused business strategy and global platform vision. Under new leadership, the company emphasizes building an AI-enabled platform serving global Chinese-speaking communities through education, media content, cross-border commerce, and i…

Buy Forward Industries: Solana Treasury Undervalued After $8 Offering

Buy Forward Industries: Solana Treasury Undervalued After $8 Offering

Forward Industries (FWDI) sells at a material discount to the implied value of its Solana treasury and operational optionality. A $25M registered direct offering at $8.00 completed on 09/24/2026 replenishes dry powder to buy SOL and increases SOL-per-share; combined with a tight float and rising technical momentum, the setup favors a tactical long …

Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026

Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026

Palisade Bio announced that its lead drug candidate, PALI-2108, designed for inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease, will be featured in four presentations at UEG Week 2026. The data showcase early clinical efficacy, gut-targeted exposure, favorable safety profile, and a biomarker development to predict treatment…

Telos Corporation Awarded $13.7 Million Contract to Modernize Cyber Risk Management for U.S. Department of Health and Human Services

Telos Corporation Awarded $13.7 Million Contract to Modernize Cyber Risk Management for U.S. Department of Health and Human Services

Telos Corporation has been awarded an $13.7 million contract by the U.S. Department of Health and Human Services to deploy its FedRAMP-authorized Xacta cybersecurity platform and related services over 18 months. The contract aims to modernize cyber governance, risk, and compliance processes for HHS, integrating AI-powered tools to streamline securi…

Lifecore Biomedical to be Acquired by Webster Equity Partners

Lifecore Biomedical to be Acquired by Webster Equity Partners

Lifecore Biomedical has agreed to be acquired by Webster Equity Partners in a transaction valued up to $663.7 million including contingent value rights based on future performance milestones. Common stockholders will receive $6.28 per share in cash at closing, representing a 49.5% premium, plus CVRs up to $160 million contingent on milestones throu…

GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit

GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit

GRI Bio, Inc., a clinical-stage biotech company developing therapies for fibrotic and autoimmune diseases, announced that its CEO and CSO will present at the upcoming 10th IPF Summit. They will share insights from Phase 2a clinical development of GRI-0621, an oral RAR β/γ-selective agonist targeting idiopathic pulmonary fibrosis (IPF). The presenta…

Cheap Permian Exposure: Buy Riley (REPX) on a Long-Term Re-rating

Cheap Permian Exposure: Buy Riley (REPX) on a Long-Term Re-rating

Riley Exploration Permian (REPX) trades like a deep-value Permian E&P with an EV/EBITDA of ~3.9x, a P/E under 8x and a $0.40 quarterly dividend. If Riley can deliver ~30% oil growth over the next year, the stock can re-rate toward mid-single-digit EV/EBITDA multiples and deliver meaningful upside. This trade outlines an entry at $40.56, a stop at $…

Cohu: Earnings Momentum Is Finally Chasing the Stock Higher

Cohu: Earnings Momentum Is Finally Chasing the Stock Higher

Cohu has already rallied hard on AI-driven test demand. Recent results and guidance show revenue growth and margin improvement that should justify further upside near-term. This is a tactical long for traders who want to ride earnings normalization into the stock while using a tight stop to limit downside if the cycle stalls.

Inflection Priced In: Fade Syntec Optics After Q2 Strength

Inflection Priced In: Fade Syntec Optics After Q2 Strength

Syntec Optics is showing real revenue and order momentum from space and biomedical customers, and Q2 commentary suggests an operational inflection. That said, the market has already bid the stock up aggressively — valuation metrics are rich, insider ownership and low free cash flow amplify execution risk, and short interest and short-volume activit…

Silexion Therapeutics Reports Positive Preclinical Findings for SIL204, Demonstrating Key Mechanism for Endogenous Systemic Uptake in KRAS-Driven Cancers

Silexion Therapeutics Reports Positive Preclinical Findings for SIL204, Demonstrating Key Mechanism for Endogenous Systemic Uptake in KRAS-Driven Cancers

Silexion Therapeutics announced promising translational research findings showing that its RNAi therapeutic candidate SIL204 leverages native serum lipids for efficient cellular uptake and potent KRAS oncogene silencing in cancer cells. This mechanism supports systemic subcutaneous administration without requiring artificial carriers, aligning with…

Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026

Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026

Achieve Life Sciences announced that it will present new data from the ORCA-OL trial demonstrating 52 weeks of cytisinicline treatment efficacy for cigarette smoking and e-cigarette cessation. The open-label study involves 475 adults and evaluates sustained abstinence, with cytisinicline showing potential as a treatment for nicotine dependence. The…